VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $112,407,000 | -29.4% | 630,155 | -12.1% | 3.48% | -22.0% |
Q2 2015 | $159,222,000 | -12.6% | 716,730 | -21.9% | 4.47% | -9.2% |
Q1 2015 | $182,186,000 | -7.7% | 917,261 | -33.5% | 4.92% | -10.7% |
Q4 2014 | $197,292,000 | -11.1% | 1,378,606 | -18.5% | 5.51% | -15.6% |
Q3 2014 | $221,928,000 | +13.4% | 1,691,525 | +9.1% | 6.53% | +10.5% |
Q2 2014 | $195,622,000 | -7.1% | 1,551,076 | -2.9% | 5.91% | -12.2% |
Q1 2014 | $210,604,000 | -3.0% | 1,597,540 | -13.6% | 6.73% | -7.5% |
Q4 2013 | $217,096,000 | +1.9% | 1,849,200 | -9.5% | 7.28% | -9.3% |
Q3 2013 | $213,129,000 | +18.2% | 2,042,835 | -2.5% | 8.02% | +9.9% |
Q2 2013 | $180,357,000 | – | 2,095,230 | – | 7.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |